Report : South America Excimer and Femtosecond Ophthalmic Lasers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Excimer Laser and Femtosecond Laser), Application (Refractive Surgery, Cataract Surgery, Capsulotomy, Trabeculoplasty, and Diagnostics), and End User (Hospitals, Ambulatory Surgical Centers, and Ophthalmology Clinics)
Ophthalmology Clinics Segment is Expected to be Fastest Growing During the Forecast Period for SAM Region
According to a new market research study on “SAM Excimer & Femtosecond Ophthalmic Lasers Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Application, and End User” is expected to reach US$ 68.01 million by 2028 from 54.23 US$ million in 2021. The market is estimated to grow at a CAGR of 3.3% from 2021 to 2028. The report provides trends prevailing in the SAM excimer & femtosecond ophthalmic lasers market along with the drivers and restraints pertaining to the market growth. Significant number of product approvals and launches is the major factor driving the growth of the SAM excimer & femtosecond ophthalmic lasers market. However, issues associated with high-cost ophthalmology surgeries and devices hinders the growth of SAM excimer & femtosecond ophthalmic lasers market.
SAM excimer & femtosecond ophthalmic lasers market is segmented into product type, application, end user, and country. SAM excimer & femtosecond ophthalmic lasers market, based on the product type was segmented into excimer laser, and femtosecond laser. In 2021, the femtosecond laser segment held the largest share of the market. SAM excimer & femtosecond ophthalmic lasers market, based on the application was segmented into refractive surgery, cataract surgery, capsulotomy, trabeculoplasty, and diagnostics. In 2021, the refractive surgery segment held the largest share of the market. Based on end user, the SAM excimer & femtosecond ophthalmic lasers market is segmented into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Based on country, the SAM excimer & femtosecond ophthalmic lasers market is segmented into Brazil, Argentina and rest of SAM. Brazil held the largest market share in 2021.
The COVID-19 outbreak critically impacted the flow of medical care in the area. Additionally, the pandemic hit medical tourism in countries of SAM. The second wave of COVID-19 infections affected Brazil, Chile, Peru, Argentina, Uruguay, and Colombia. The SARS-CoV-2 pandemic had a sudden, dramatic impact on the healthcare of the SAM region. The COVID-19 pandemic has shifted the accepted and routine treatment of elective cases in hospital administration. In Brazil, patient care fell by almost 60%, and operations were scaled back, allowing only emergency options. These include cataracts, retina, and laser surgery. Glaucoma patients who urgently need an intraocular pressure reduction were still operated on. Strict social distancing procedures were applied, with patients being admitted to the clinic unaccompanied and individually. COVID-19 has changed everyday life almost all over the region.
Alcon Inc.; Bausch Health Companies Inc.; Carl Zeiss AG; SCHWIND eye-tech-solutions; and Ziemer Ophthalmic Systems are among the leading companies in the SAM excimer & femtosecond ophthalmic lasers market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, SCHWIND eye-tech-solutions has received CE approval for the SCHWIND ATOS femtosecond laser. This enables refractive surgeons to offer their patients SmartSight, lenticular extraction developed by SCHWIND, as a treatment option.
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org